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received a booster dose. H influenzae type b polysaccha›
ride IgG responses are shown in the table. The propor›
tions of children who had antibody titres below the
minimum protective level of 0.15ìg/ml before
receiving their booster dose at 1 year of age was higher
than previously reported with the more extended pri›
mary immunisation schedule.5 The mean increase in
antibody titre after administration of the booster dose
was 803›fold (95% confidence interval 651 to 955).
Comment
This increase in antibody titres after booster immun›
isation is consistent with an immunological memory
response, and shows that the children’s immune
systems were successfully primed by the three doses of
conjugate vaccine they received during infancy. Immu›
nological memory induced by vaccines administered
according to the accelerated primary schedule may
provide long term protection even when circulating
antibody titres are low. Conjugate vaccines against H
influenzae type b could be introduced into the
expanded immunisation programme of the WHO
using a schedule of three doses in infancy and no
booster dose. This should enhance deliverability and
reduce costs.
Contributors: DG and EM designed the study. KC and EM
coordinated the recruitment of patients and their follow up. DG
and NM were responsible for developing the laboratory assay.
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study.
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Initiatives to improve childhood immunisation uptake:
a randomised controlled trial
Maria Z Morgan, Meirion R Evans
Levels of childhood immunisation are high in the
United Kingdom but are proving difficult to maintain.
Several initiatives to improve uptake have been
described, including sending written information to
parents,1 specialist immunisation clinics,2 and prompts
to health visitors and general practitioners.3 However,
none of these interventions has been the subject of a
randomised controlled trial. We tested the effectiveness
of two such interventions.
Subjects, methods, and results
The child health system, which maintains computer›
ised data on immunisation status of all children, was
used as the sampling frame. The study population
comprised children resident in the former county of
South Glamorgan who were (a) born between 1 April
and 30 September 1995 and scheduled to complete
the primary course of diphtheria, pertussis, tetanus,
polio, and Haemophilus influenzae type b immunisation
or (b) born between 1 April and 30 September 1994
and scheduled to receive measles, mumps, and rubella
immunisation. Children were included in the trial if
they had not completed their primary course by
9 months of age or their measles, mumps, and rubella
immunisation by 21 months of age.
Each week between 1 January and 30 June 1996 we
received a computer generated list of children eligible
for inclusion in the study and randomised each child
using computer generated random numbers to one of
two interventions or a control group. Intervention A
comprised a non›directive telephone call to the child’s
health visitor to confirm the child’s personal details
and immunisation status. The health visitor was not
informed of the trial and, although follow up of the
child was anticipated, it was not specifically requested.
Intervention B comprised a single mailed reminder to
the child’s parents together with a questionnaire about
details of immunisation status and reasons for
non›immunisation, and a reply paid envelope. Parents
were not informed of the trial.
Study end points were completion of (a) primary
immunisation by the first birthday or (b) measles,
mumps, and rubella immunisation by the second
birthday. We performed statistical analysis on an inten›
tion to treat basis, using the ÷2 test with Yates’s correc›
tion for baseline comparisons, and calculated 95%
confidence intervals for the difference in proportions.
Geometric mean titre (95% confidence interval) of Haemophilus influenzae type b
polysaccharide IgG, and the number (percentage) of infants with antibody titres below
the minimum protective concentration (0.15ìg/ml) or above the long term protective
concentration (1.0ìg/ml) after primary immunisation with three doses of conjugate
vaccine, and immediately before and 1 month after a booster dose of the vaccine given
at 1 year of age
No Geometric mean titre
Antibody titre
<0.15ìg/ml >1.0ìg/ml
After primary immunisation 516 6.23 (5.53 to 7.01) 10 (2) 478 (93)
Immediately before booster dose 401 0.41 (0.35 to 0.47) 153 (38) 126 (31)
1 month after booster dose 387 108.39 (91.62 to 128.23) 7 (2) 380 (98)
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In total, 153 children (76 primary course and 77
measles, mumps, and rubella immunisation) were ran›
domised to intervention A, 159 children (82 primary
course and 77 measles, mumps, and rubella immunisa›
tion) to intervention B, and 139 children (74 primary
course and 65 measles, mumps, and rubella immunisa›
tion) to the control group. The study had a power of
80% to show a 15% difference between each interven›
tion and the control group at 5% two sided
significance. Distribution of baseline characteristics in
the three groups was similar. There was no significant
difference between either intervention group and the
control group in the proportion completing the
primary course or measles, mumps, and rubella immu›
nisation (see table). Nor was there a significant
difference in study end point, when both interventions
combined were compared with the control group. Sub›
group analysis by maternal age and parity showed a
substantial but non›significant effect of intervention in
promoting completion of primary immunisation in
firstborn children (56%, 10/18) compared with
firstborn controls (25%, 3/12), and in children of
young mothers aged <30 years (31%, 27/86)
compared with controls (13%, 5/38). There was no
effect on uptake of measles, mumps, and rubella
immunisation.
Comment
Randomised controlled trials provide the best evidence
for effectiveness of interventions. However, we found
only one other trial of an intervention to promote child›
hood immunisation. This was carried out in preschool
children in the United States and found that a computer
generated telephone reminder resulted in a significant
but modest improvement of 12% in immunisation
uptake in the intervention group, after excluding the
20% of households with no telephone.4
Neither intervention we studied improved immuni›
sation uptake. The results suggest that district›wide ini›
tiatives directed at individual families are unlikely to be
worth while, although there may be some benefit from
targeting young or primiparous mothers. There is evi›
dence that initiatives by primary healthcare teams such
as opportunistic immunisation of children attending
the surgery and domiciliary immunisation by nurses
can improve uptake,5 although these approaches
would benefit from more formal evaluation. More use
should be made of randomised controlled trials to
evaluate interventions to promote uptake of preventive
services in primary care.
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Baseline characteristics and immunisation uptake in intervention and control groups.
Values are numbers (percentages) of subjects unless stated otherwise
Intervention A
(n=153)
Intervention B
(n=159) Control (n=139)
Sex:
Male 70 (46) 79 (50) 71 (51)
Female 83 (54) 80 (50) 68 (49)
Ethnic group:
White 117 (76) 125 (79) 111 (80)
Other 36 (24) 34 (21) 28 (20)
Mean (SD) maternal age (years) 28.4 (5.3) 27.7 (5.7) 29.7 (5.5)
Median (range) maternal parity 1.3 (0›7) 1.5 (0›7) 1.5 (0›8)
Immunisation uptake*:
Any immunisation 46 (30) 42 (26) 45 (32)
Primary course 25/76 (33) 24/82 (29) 23/74 (31)
Measles, mumps, and rubella 21/77 (27) 18/77 (23) 22/65 (34)
*95% Confidence intervals for difference in proportion between intervention groups and control group
(values are percentages): any immunisation—intervention A −2.3 (−13.0 to 8.4), intervention B −6.0 (−16.4
to 4.4); primary course—intervention A 2.2 (−12.9 to 17.3), intervention B −1.5 (−15.9 to 12.9); measles,
mumps, and rubella—intervention A −6.5 (−21.7 to 8.7), intervention B −9.8 (−24.7 to 5.1).
Memorable patients
Doing as they are told
We all worry about patients’ compliance. However, this is not the
hazard. Occasionally advice can be taken too literally.
A young woman brought her baby to see me on account of
nappy rash. The baby did not look ill and I asked the mother to
undress her. I was horrified by the sight of a baby seemingly
consisting of skin and bones. The only time I had seen anything
like it was an illustration of marasmus in a textbook. On inquiring
what kind of food the baby was having, the mother told me that it
was Robinson’s Patent Barley. “How was it made up?” “With
water.” “What else do you give her?” A blank stare. “No milk?”
“No, my mother said I was brought up on Robinson’s Patent
Barley and I was always a bonny baby.” The mother had obviously
failed to mention that Robinson’s Patent Barley was to be given in
addition to and not instead of milk.
Once I was called to see a man in his 60s because “his legs had
turned blue.” I found a slightly obese man, fussed over by his wife.
He had the most extensive ecchymoses on both legs and also on
other parts of his body. On inquiry it turned out that he had had
a duodenal ulcer some years before. He was then advised to have
plenty of milk drinks and milk puddings. That was indeed the diet
his wife kept him on to the exclusion of all other food; she was
very proud of it. Thus I saw what must have been the only case of
scurvy in south Yorkshire.
Perhaps we are sometimes too emphatic and not sufficiently
explicit in advising our patients.
Otto Fleming, retired general practitioner, Sheffield
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